Tower Research Capital (TRC)’s Clovis Oncology, Inc. CLVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-660
Closed 6779
2022
Q4
$0 Sell
660
-10,029
-94% -$6.59K ﹤0.01% 6775
2022
Q3
$13K Sell
10,689
-8,239
-44% -$12.8K ﹤0.01% 4314
2022
Q2
$35K Sell
18,928
-97,743
-84% -$144K ﹤0.01% 3235
2022
Q1
$236K Buy
116,671
+66,419
+132% +$130K ﹤0.01% 1614
2021
Q4
$136K Sell
50,252
-8,327
-14% -$30.8K ﹤0.01% 2037
2021
Q3
$262K Buy
58,579
+42,653
+268% +$205K 0.01% 1561
2021
Q2
$92K Buy
15,926
+10,840
+213% +$63.5K ﹤0.01% 2501
2021
Q1
$36K Sell
5,086
-4,436
-47% -$29.7K ﹤0.01% 3409
2020
Q4
$46K Sell
9,522
-99,219
-91% -$502K ﹤0.01% 3202
2020
Q3
$634K Buy
108,741
+60,152
+124% +$360K 0.01% 1420
2020
Q2
$328K Buy
+48,589
New +$368K 0.01% 1368
2020
Q1
Sell
-222
Closed -$2K 4210
2019
Q4
$2K Sell
222
-299
-57% -$2.17K ﹤0.01% 3155
2019
Q3
$2K Buy
521
+384
+280% +$3.11K ﹤0.01% 3775
2019
Q2
$2K Sell
137
-480
-78% -$8.67K ﹤0.01% 3353
2019
Q1
$15K Buy
617
+517
+517% +$13K ﹤0.01% 2457
2018
Q4
$2K Buy
+100
New +$2.04K ﹤0.01% 3475
2018
Q2
Sell
-48
Closed -$3K 4224
2018
Q1
$3K Sell
48
-583
-92% -$34K ﹤0.01% 2895
2017
Q4
$43K Sell
631
-2,372
-79% -$166K 0.01% 1448
2017
Q3
$248K Buy
+3,003
New +$238K 0.02% 609
2017
Q2
Sell
-93
Closed -$6K 3662
2017
Q1
$6K Sell
93
-4,400
-98% -$267K ﹤0.01% 2137
2016
Q4
$200K Buy
+4,493
New +$158K 0.02% 629
2016
Q3
Sell
-7,105
Closed -$98K 4714
2016
Q2
$98K Buy
7,105
+5,813
+450% +$85K 0.01% 1118
2016
Q1
$25K Sell
1,292
-417
-24% -$8.83K ﹤0.01% 1204
2015
Q4
$60K Buy
+1,709
New +$110K 0.01% 475
2015
Q3
Sell
-368
Closed -$32K 5013
2015
Q2
$32K Sell
368
-740
-67% -$63.3K ﹤0.01% 1728
2015
Q1
$82K Buy
1,108
+1,071
+2,895% +$75.6K 0.01% 1057
2014
Q4
$2K Sell
37
-59
-61% -$3.1K ﹤0.01% 3425
2014
Q3
$4K Sell
96
-180
-65% -$7.52K ﹤0.01% 3489
2014
Q2
$11K Sell
276
-1,030
-79% -$53K ﹤0.01% 2301
2014
Q1
$90K Buy
1,306
+650
+99% +$47.7K 0.01% 766
2013
Q4
$40K Sell
656
-529
-45% -$28.8K 0.01% 1589
2013
Q3
$72K Buy
1,185
+35
+3% +$2.48K 0.01% 1598
2013
Q2
$77K Buy
+1,150
New +$51.7K 0.01% 644

Other funds holding CLVS